Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study

Gretchen L Gierach*, James V Lacey, Arthur Schatzkin, Michael F Leitzmann, Douglas Richesson, Albert R Hollenbeck and Louise A Brinton

Breast Cancer Research 2008, 10:R38 doi:10.1186/bcr2089

Accesses  

  • Last 30 days: 97 accesses
  • Last 365 days: 1236 accesses
  • All time: 10473 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer

Holger Bronger, Sara Kraeft, Ulrike Schwarz-Boeger, Claudia Cerny, Alexandra Stöckel, Stefanie Avril, Marion Kiechle, Manfred Schmitt Breast Cancer Research 2012, 14:R30 (14 February 2012)

Research article   Open Access Highly Accessed

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study

Deirdre P Cronin-Fenton, Lars Pedersen, Timothy L Lash, Søren Friis, John A Baron, Henrik T Sørensen Breast Cancer Research 2010, 12:R15 (1 March 2010)